Close

Endologix (ELGX) Reports In-Line Q3 Loss of 13c/Share

October 30, 2014 4:24 PM EDT

Endologix (NASDAQ: ELGX) reported Q3 EPS of ($0.13), in-line with the analyst estimate of ($0.13). Revenue for the quarter came in at $37.2 million versus the consensus estimate of $37 million.

For earnings history and earnings-related data on Endologix (ELGX) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings